Scigenics Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 9.90 M
as on 13-12-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.74 M
as on 13-12-2024
- Satisfied Charges ₹ 2.63 Cr
as on 13-12-2024
- Revenue 16.73%
(FY 2022)
- Profit -2.19%
(FY 2022)
- Ebitda -16.11%
(FY 2022)
- Net Worth 21.07%
(FY 2022)
- Total Assets 11.00%
(FY 2022)
About Scigenics Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹0.74 M. The company has closed loans amounting to ₹2.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satyamurty Gopal and Neela Saravanakumar serve as directors at the Company.
- CIN/LLPIN
U24294TN1997PTC038155
- Company No.
038155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Scigenics Biotech Private Limited offer?
Scigenics Biotech Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Electromedical Equipment, Plastic & Glass Labware, Laboratory Plasticware, Autoclaves, Sterilizers & Incubators, Lab Incubator, Laboratory & Lab Equipment, Laboratory Shakers, Laboratory Consumables, Adjustable Flask Holder.
Who are the key members and board of directors at Scigenics Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neela Saravanakumar  | Managing Director | 05-Mar-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyamurty Gopal | Director | 12-May-1997 | Current |
Financial Performance of Scigenics Biotech.
Scigenics Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.73% increase. The company also saw a slight decrease in profitability, with a 2.19% decrease in profit. The company's net worth Soared by an impressive increase of 21.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scigenics Biotech?
Unlock access to Scigenics Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Symbiogen Biotechnologies Private LimitedActive 17 years 9 monthsSatyamurty Gopal and Neela Saravanakumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 07 Feb 2024 | ₹0.74 M | Open |
Department Of Biotechnology Creation Date: 13 Apr 2009 | ₹9.50 M | Satisfied |
Canara Bank Creation Date: 21 Apr 2008 | ₹1.49 Cr | Satisfied |
How Many Employees Work at Scigenics Biotech?
Scigenics Biotech has a workforce of 51 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scigenics Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scigenics Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
